Community Research and Development Information Service - CORDIS

  • European Commission
  • CORDIS
  • Projects and Results
  • Clinical proof of concept through a randomised phase II study: a combination of immunotherapy and stereotactic ablative radiotherapy as a curative treatment for limited metastatic lung cancer
H2020

IMMUNOSABR

Project ID: 733008
Funded under

Clinical proof of concept through a randomised phase II study: a combination of immunotherapy and stereotactic ablative radiotherapy as a curative treatment for limited metastatic lung cancer

From 2017-01-01 to 2022-12-31, ongoing project

Project details

Total cost:

EUR 7 951 268,50

EU contribution:

EUR 5 994 176,25

Coordinated in:

Netherlands

Call for proposal:

H2020-SC1-2016-RTDSee other projects for this call

Funding scheme:

RIA - Research and Innovation action

Objective

Coordinator

UNIVERSITEIT MAASTRICHT
Netherlands

EU contribution: EUR 1 093 575


Minderbroedersberg 4-6
6200 MD MAASTRICHT
Netherlands
Activity type: Higher or Secondary Education Establishments

Participants

DANMARKS TEKNISKE UNIVERSITET
Denmark

EU contribution: EUR 1 078 407,50


Anker Engelundsvej 1, Building 101A
2800 KONGENS LYNGBY
Denmark
Activity type: Higher or Secondary Education Establishments
ACADEMISCH ZIEKENHUIS MAASTRICHT
Netherlands

EU contribution: EUR 388 581,25


P DEBYELAAN 25
6229 HX MAASTRICHT
Netherlands
Activity type: Research Organisations
KATHOLIEKE UNIVERSITEIT LEUVEN
Belgium

EU contribution: EUR 238 850


Oude Markt 13
3000 LEUVEN
Belgium
Activity type: Higher or Secondary Education Establishments
UNIVERSITA CATTOLICA DEL SACRO CUORE
Italy

EU contribution: EUR 157 231,25


Largo Agostino Gemelli 1
20123 MILANO
Italy
Activity type: Higher or Secondary Education Establishments
Stichting Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek ziekenhuis
Netherlands

EU contribution: EUR 157 231,25


Plesmanlaan
1066 CX Amsterdam
Netherlands
Activity type: Research Organisations
Universitair Ziekenhuis Gent
Belgium

EU contribution: EUR 157 231,25


De Pintelaan 185
9000 Gent
Belgium
Activity type: Research Organisations
CLINIQUES UNIVERSITAIRES SAINT-LUC
Belgium

EU contribution: EUR 157 231,25


AVENUE HIPPOCRATE 10
1200 BRUXELLES
Belgium
Activity type: Research Organisations
CENTRE OSCAR LAMBRET
France

EU contribution: EUR 157 231,25


RUE FREDERIC COMBEMALE 3
59020 LILLE
France
Activity type: Other
EBERHARD KARLS UNIVERSITAET TUEBINGEN
Germany

EU contribution: EUR 318 850


GESCHWISTER-SCHOLL-PLATZ
72074 TUEBINGEN
Germany
Activity type: Higher or Secondary Education Establishments
University College London
United Kingdom

EU contribution: EUR 157 231,25


Gower Street
WC1E 6BT London
United Kingdom
Activity type: Higher or Secondary Education Establishments
TECHNISCHE UNIVERSITAET DRESDEN
Germany

EU contribution: EUR 207 231,25


HELMHOLTZSTRASSE 10
01069 DRESDEN
Germany
Activity type: Higher or Secondary Education Establishments
Stichting Katholieke Universiteit / Radboud university medical center
Netherlands

EU contribution: EUR 157 231,25


Geert Grooteplein Noord
6525 EZ Nijmegen
Netherlands
Activity type: Higher or Secondary Education Establishments
PHILOGEN SPA
Italy

EU contribution: EUR 726 250


PIAZZA LA LIZZA 7
53100 SIENA
Italy
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
HEALTH INNOVATION VENTURES BV
Netherlands

EU contribution: EUR 434 250


BOSCHSTRAAT 111 D 01
6211 AW MAASTRICHT
Netherlands
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
PT THERAGNOSTIC BV
Netherlands

EU contribution: EUR 312 500


BOSCHSTRAAT 111 D 01
6211 AW MAASTRICHT
Netherlands
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
EUROPEAN CANCER PATIENT COALITION
Belgium

EU contribution: EUR 95 062,50


CHURCHILLLAAN 11-2
3527GV UTRECHT
Netherlands
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top